Nexthera Capital’s Timber Pharmaceuticals, Inc. TMBR Stock Holding History

Nexthera Capital’s Portfolio TMBR Stock Details TMBR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-4	Closed	-$32K	–	49
2016 Q3	$32K	Buy	+4	New	+$42.2K	0.02%	33
2016 Q2	–	Sell	-23	Closed	-$377K	–	42
2016 Q1	$377K	Buy	+23	New	+$521K	0.39%	29

Other funds holding TMBR

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

SCM

Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PAM

Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return

DCM

DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Nexthera Capital's TMBR Position: Q4 2016 in Review

Nexthera Capital sold out of Timber Pharmaceuticals, Inc. (TMBR) in Q4 2016, closing a stake of 4 shares — an estimated $32K sold.

Nexthera Capital first reported a position in TMBR in Q1 2016 and held it in 2 quarters. The position peaked at $377K in Q1 2016. 14 funds tracked by Wall St. Rank hold TMBR as of Q4 2016.

Nexthera Capital reported no remaining Timber Pharmaceuticals, Inc. position as of Q4 2016 after selling out during the quarter.
Nexthera Capital sold 4 Timber Pharmaceuticals, Inc. shares in Q4 2016, an estimated $32K.
Nexthera Capital first reported a position in Timber Pharmaceuticals, Inc. in Q1 2016 and held it in 2 quarters.
Nexthera Capital's Timber Pharmaceuticals, Inc. position peaked at $377K in Q1 2016.
14 funds tracked by Wall St. Rank held Timber Pharmaceuticals, Inc. as of Q4 2016.

Based on Nexthera Capital's 13F filing for Q4 2016, filed 14 Feb 2017.